This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1352458507082354v1 1352458507082354v2 14/2/205    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fazekas, F. Articles by Wallner, M. Search for Related Content PubMed PubMed Citation Articles by Fazekas, F. Articles by Wallner, M. Pubmed/NCBI databases Medline Plus Health Information MRI Scans Social Bookmarking                         What's this?

Clinically benign multiple sclerosis despite large T2 lesion load: Can we explain this paradox?

Department of Neurology, Division of Neuroradiology, Medical University, Graz, Austria

^* To whom correspondence should be addressed.

	Abstract

Magnetic resonance imaging (MRI) techniques such as magnetization transfer imaging and magnetic resonance spectroscopy (MRS) may reveal otherwise undetectable tissue damage in multiple sclerosis (MS) and can serve to explain more severe disability than expected from conventional MRI. That an inverse situation may exist where non-conventional quantitative MRI and MRS metrics would indicate less abnormality than expected from T2 lesion load to explain preserved clinical functioning was hypothesized. Quantitative MRI and MRS were obtained in 13 consecutive patients with clinically benign MS (BMS; mean age 44±9 years) despite large T2 lesion load and in 15 patients with secondary progressive MS (SPMS; mean age 47±6 years) matched for disease duration. The magnetization transfer ratio (MTR), magnetization transfer rate (k _for), brain parenchymal fraction (BPF) and brain metabolite concentrations from proton MRS were determined. BMS patients were significantly less disabled than their SPMS counterparts (mean expanded disability status score: 2.1±1.1 versus 6.2±1.1; P<0.001) and had an even somewhat higher mean T2 lesion load (41.2±27.1 versus 27.9±24.8 cm3; P=0.19). Normal appearing brain tissue histogram metrics for MTR and k _for, mean MTR and k _for of MS lesions and mean BPF were similar in BMS and SPMS patients. Levels of N-acetylaspartate, choline and myoinositol were comparable between groups. This study thus failed to explain the preservation of function in our BMS patients with large T₂ lesion load by a higher morphologic or metabolic integrity of the brain parenchyma. Functional compensation must come from other mechanisms such as brain plasticity.

Key Words: magnetic resonance imaging; magnetic resonance spectroscopy; multiple sclerosis

First published on November 6, 2007, doi:10.1177/1352458507082354

Multiple Sclerosis 2008;14:205.

A more recent version of this article appeared on March 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. H.B. Benedict and F. Fazekas Benign or not benign MS: A role for routine neuropsychological assessment? Neurology, August 18, 2009; 73(7): 494 - 495. [Full Text] [PDF]

				B Benedetti, M Rovaris, M. Rocca, D Caputo, M Zaffaroni, R Capra, A Bertolotto, V Martinelli, G Comi, and M Filippi In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis Multiple Sclerosis, July 1, 2009; 15(7): 789 - 794. [Abstract] [PDF]

				A Ceccarelli, M Filippi, M Neema, A Arora, P Valsasina, M. Rocca, B. Healy, and R Bakshi T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis Multiple Sclerosis, June 1, 2009; 15(6): 678 - 686. [Abstract] [PDF]

				M. Rovaris, F. Barkhof, M. Calabrese, N. De Stefano, F. Fazekas, D. H. Miller, X. Montalban, C. Polman, M. A. Rocca, A. J. Thompson, et al. MRI features of benign multiple sclerosis: Toward a new definition of this disease phenotype Neurology, May 12, 2009; 72(19): 1693 - 1701. [Abstract] [Full Text] [PDF]

				S. A. Gauthier, A. M. Berger, Z. Liptak, Y. Duan, S. Egorova, G. J. Buckle, B. I. Glanz, S. J. Khoury, R. Bakshi, H. L. Weiner, et al. Rate of Brain Atrophy in Benign vs Early Multiple Sclerosis Arch Neurol, February 1, 2009; 66(2): 234 - 237. [Abstract] [Full Text] [PDF]

				M Calabrese, M Filippi, M Rovaris, V Bernardi, M Atzori, I Mattisi, A Favaretto, P Grossi, L Barachino, L Rinaldi, et al. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study Multiple Sclerosis, January 1, 2009; 15(1): 36 - 41. [Abstract] [PDF]

				M. Rovaris, G. Riccitelli, E. Judica, F. Possa, D. Caputo, A. Ghezzi, A. Bertolotto, R. Capra, M. Falautano, F. Mattioli, et al. Cognitive impairment and structural brain damage in benign multiple sclerosis Neurology, November 4, 2008; 71(19): 1521 - 1526. [Abstract] [Full Text] [PDF]

				M. P. Amato, E. Portaccio, M. L. Stromillo, B. Goretti, V. Zipoli, G. Siracusa, M. Battaglini, A. Giorgio, M. L. Bartolozzi, L. Guidi, et al. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis Neurology, August 26, 2008; 71(9): 632 - 638. [Abstract] [Full Text] [PDF]